首页> 外文期刊>Oral oncology >Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
【24h】

Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.

机译:蛋白质组学分析头颈部鳞状细胞癌的激光捕获显微切割和串联质谱。

获取原文
获取原文并翻译 | 示例

摘要

Remarkable progress has been made to identify genes expressed in squamous cell carcinomas of the head and neck (HNSCC). However, limited information is available on their corresponding protein products, whose expression, post-translational modifications, and activity are ultimately responsible for the malignant behavior of this tumor type. We have combined laser-capture microdissection (LCM) with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify proteins expressed in histologically normal squamous epithelium and matching SCC. The protein fraction from approximately 10,000-15,000 normal and tumor cells was solubilized, digested with trypsin, and the resulting peptides were analyzed by LC-MS/MS. Database searching of the resulting sequence information identified 30-55 proteins per sample. Keratins were the most abundant proteins in both normal and tumor tissues. Among the proteins differentially expressed, keratin 13 was much lower in tumors, whereas heat-shock (Hsp) family members were highly expressed in neoplastic cells. Wnt-6 and Wnt-14 were identified in both normal and tumor tissues, respectively, and placental growth factor (PIGF) was detected only in tumors. Immunohistochemical analysis of HNSCC tissues revealed lack of keratin 13 in tumor tissues, and strong staining in normal epithelia, and high expression of Hsp90 in tumors. Our study, by combining LCM and proteomic technologies, underscores the advantages of this approach to investigate complex changes at the protein level in HNSCC, thus complementing existing and emerging genomic technologies. These efforts may likely result in the identification of new biomarkers for HNSCC that can be used to diagnose disease, predict susceptibility, and monitor progression in individual patients.
机译:鉴定在头颈部鳞状细胞癌(HNSCC)中表达的基因已取得了显着进展。但是,有关其相应蛋白质产品的信息有限,其表达,翻译后修饰和活性最终决定了该肿瘤类型的恶性行为。我们将激光捕获显微切割术(LCM)与液相色谱-串联质谱(LC-MS / MS)结合使用,以鉴定在组织学上正常的鳞状上皮和匹配的SCC中表达的蛋白质。将来自大约10,000-15,000个正常细胞和肿瘤细胞的蛋白质部分溶解,用胰蛋白酶消化,然后通过LC-MS / MS分析所得的肽。对所得序列信息进行数据库搜索后,每个样品鉴定出30-55种蛋白质。角蛋白是正常组织和肿瘤组织中最丰富的蛋白质。在差异表达的蛋白质中,角蛋白13在肿瘤中低得多,而热休克(Hsp)家族成员在赘生性细胞中高度表达。 Wnt-6和Wnt-14分别在正常组织和肿瘤组织中鉴定,并且胎盘生长因子(PIGF)仅在肿瘤中检出。 HNSCC组织的免疫组织化学分析显示,肿瘤组织中缺乏角蛋白13,正常上皮细胞染色强烈,肿瘤中Hsp90高表达。我们的研究结合了LCM和蛋白质组学技术,强调了这种方法的优势,可以研究HNSCC中蛋白质水平的复杂变化,从而补充了现有和新兴的基因组技术。这些努力可能会导致鉴定HNSCC的新生物标志物,这些标志物可用于诊断疾病,预测易感性并监测单个患者的病情发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号